483
Merck Life Science Technologies (Nantong) Co., Ltd.Merck Life Science Technologies (Nantong) Co., Ltd. – FDA 483, Mar 14, 2025
Record Details
An FDA inspection of Merck life Science Technologies (Nantong) Co. Ltd, an excipients and API manufacturer, revealed significant quality control deficiencies. The firm failed to thoroughly investigate customer complaints and deviations, lacked adequate procedures to prevent microbiological contamination of non-sterile products, and had an insufficient stability program. Additionally, the company did not base material sampling amounts on appropriate criteria.
- Inspection date
- March 14, 2025
- Product type
- drugs
View Company Profile
ID · c60898bc-ea02-4476-adfa-14e5848fe394
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.